Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation.
about
Hepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesRisk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease.Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
P2860
Systemic diseases and biotherapies: understanding, evaluating, and preventing the risk of hepatitis B reactivation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systemic diseases and biothera ...... k of hepatitis B reactivation.
@en
type
label
Systemic diseases and biothera ...... k of hepatitis B reactivation.
@en
prefLabel
Systemic diseases and biothera ...... k of hepatitis B reactivation.
@en
P2093
P1433
P1476
Systemic diseases and biothera ...... k of hepatitis B reactivation.
@en
P2093
Alexandra Ducancelle
Charles Masson
Françoise Lunel-Fabiani
P304
P356
10.1016/J.JBSPIN.2014.01.015
P577
2014-02-20T00:00:00Z